These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 23592979

  • 1. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L.
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [Abstract] [Full Text] [Related]

  • 4. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.
    Arthritis Res; 2000 Jul; 2(2):154-64. PubMed ID: 11062606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease.
    Kohrt H, Johannsen A, Hoppe R, Horning SJ, Rosenberg SA, Advani R, Lee PP.
    Oncol Res; 2009 Jul; 18(5-6):287-92. PubMed ID: 20225766
    [Abstract] [Full Text] [Related]

  • 9. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    Catalina MD, Sullivan JL, Bak KR, Luzuriaga K.
    J Immunol; 2001 Oct 15; 167(8):4450-7. PubMed ID: 11591771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal.
    Serafini B, Scorsi E, Rosicarelli B, Rigau V, Thouvenot E, Aloisi F.
    J Neuroimmunol; 2017 Jun 15; 307():14-17. PubMed ID: 28495131
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.
    J Neurol Neurosurg Psychiatry; 2009 May 15; 80(5):498-505. PubMed ID: 19015225
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb 15; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

  • 18. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C, Aloisi F.
    Front Immunol; 2021 Feb 15; 12():665718. PubMed ID: 34305896
    [Abstract] [Full Text] [Related]

  • 19. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P, Hansen HJ, Haahr S.
    Clin Exp Immunol; 2003 Apr 15; 132(1):137-43. PubMed ID: 12653848
    [Abstract] [Full Text] [Related]

  • 20. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
    Abbadessa G, Lepore MT, Bruzzaniti S, Piemonte E, Miele G, Signoriello E, Perna F, De Falco C, Lus G, Matarese G, Bonavita S, Galgani M.
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul 15; 11(4):e200250. PubMed ID: 38662990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.